165 related articles for article (PubMed ID: 22143060)
21. Update on signal inhibitors in chronic lymphocytic leukemia.
Boddu P; Jain N
Clin Adv Hematol Oncol; 2018 Apr; 16(4):279-288. PubMed ID: 29742083
[TBL] [Abstract][Full Text] [Related]
22. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
23. Chronic lymphocytic leukemia (CLL): first-line treatment.
Hallek M;
Hematology Am Soc Hematol Educ Program; 2005; ():285-91. PubMed ID: 16304393
[TBL] [Abstract][Full Text] [Related]
24. Chronic Lymphocytic Leukemia: A Review of Front-line Treatment Options, With a Focus on Elderly CLL Patients.
O'Reilly A; Murphy J; Rawe S; Garvey M
Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):249-256. PubMed ID: 29477297
[TBL] [Abstract][Full Text] [Related]
25. Chronic lymphocytic leukemia and focusing on epidemiology and management in everyday hematologic practice: recent data from the Czech Leukemia Study Group for Life (CELL).
Panovská A; Doubek M; Brychtová Y; Mayer J
Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):297-300. PubMed ID: 20709668
[TBL] [Abstract][Full Text] [Related]
26. Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
Byrd JC; Gribben JG; Peterson BL; Grever MR; Lozanski G; Lucas DM; Lampson B; Larson RA; Caligiuri MA; Heerema NA
J Clin Oncol; 2006 Jan; 24(3):437-43. PubMed ID: 16344317
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia.
Rai KR
J Hematol Oncol; 2015 Jul; 8():85. PubMed ID: 26170206
[TBL] [Abstract][Full Text] [Related]
28. Treatment options in chronic lymphocytic leukemia.
Montserrat E
Hematol J; 2004; 5 Suppl 1():S2-9. PubMed ID: 15079148
[TBL] [Abstract][Full Text] [Related]
29. Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.
Khan M; Siddiqi R; Thompson PA
Ann Hematol; 2018 Jan; 97(1):1-15. PubMed ID: 29063177
[TBL] [Abstract][Full Text] [Related]
30. Improving treatment for patients with chronic lymphocytic leukemia.
Shanafelt TD
Hematology; 2012 Apr; 17 Suppl 1():S133-6. PubMed ID: 22507801
[TBL] [Abstract][Full Text] [Related]
31. How I treat CLL up front.
Gribben JG
Blood; 2010 Jan; 115(2):187-97. PubMed ID: 19850738
[TBL] [Abstract][Full Text] [Related]
32. A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL.
Jain N; Balakrishnan K; Ferrajoli A; O'Brien SM; Burger JA; Kadia TM; Cortes JE; Ayres ML; Tambaro FP; Keating MJ; Gandhi V; Wierda WG
Oncotarget; 2017 Mar; 8(13):22104-22112. PubMed ID: 27655665
[TBL] [Abstract][Full Text] [Related]
33. Diagnosing and treating chronic lymphocytic leukemia in 2009.
Kaufman M; Rubin J; Rai K
Oncology (Williston Park); 2009 Nov; 23(12):1030-7. PubMed ID: 20017285
[TBL] [Abstract][Full Text] [Related]
34. Beyond detectable minimal residual disease in chronic lymphocytic leukemia.
Hillmen P
Semin Oncol; 2006 Apr; 33(2 Suppl 5):S23-8. PubMed ID: 16720200
[TBL] [Abstract][Full Text] [Related]
35. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
[TBL] [Abstract][Full Text] [Related]
36. Purine analogue-based chemotherapy regimens for second-line therapy in patients with chronic lymphocytic leukemia.
Lamanna N; Weiss MA
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S44-9. PubMed ID: 16549114
[TBL] [Abstract][Full Text] [Related]
37. Chronic lymphocytic leukemia: diagnosis and treatment.
Yee KW; O'Brien SM
Mayo Clin Proc; 2006 Aug; 81(8):1105-29. PubMed ID: 16901035
[TBL] [Abstract][Full Text] [Related]
38. Early intervention in asymptomatic chronic lymphocytic leukemia.
Muchtar E; Kay NE; Parikh SA
Clin Adv Hematol Oncol; 2021 Feb; 19(2):92-103. PubMed ID: 33596191
[TBL] [Abstract][Full Text] [Related]
39. Controversies in the front-line management of chronic lymphocytic leukemia.
Nabhan C; Shanafelt TD; Kay NE
Leuk Res; 2008 May; 32(5):679-88. PubMed ID: 18191201
[TBL] [Abstract][Full Text] [Related]
40. Chronic lymphocytic leukaemia: up-dated recommendations on diagnosis and treatment.
Hallek M; Bergmann M; Emmerich B
Onkologie; 2004 Feb; 27(1):97-104. PubMed ID: 15007256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
